Oscar Health (NYSE:OSCR) Shares Gap Down – Time to Sell?

Oscar Health, Inc. (NYSE:OSCR) gapped down prior to trading on Friday . The stock had previously closed at $12.51, but opened at $11.89. Oscar Health shares last traded at $12.1570, with a volume of 1,592,820 shares traded.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on OSCR shares. Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Piper Sandler upgraded Oscar Health from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $13.00 to $25.00 in a report on Tuesday, November 25th. Wells Fargo & Company decreased their price objective on Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a report on Thursday, November 13th. Barclays set a $18.00 price target on shares of Oscar Health and gave the stock an “equal weight” rating in a research note on Monday, January 5th. Finally, Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, December 6th. One investment analyst has rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Reduce” and an average price target of $17.00.

Oscar Health Stock Performance

The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92. The stock has a fifty day simple moving average of $15.71 and a two-hundred day simple moving average of $16.75. The stock has a market cap of $3.26 billion, a price-to-earnings ratio of -11.00 and a beta of 1.90.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. The business had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company’s quarterly revenue was up 23.2% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.22) EPS. Analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Insider Activity

In other Oscar Health news, insider Mario Schlosser sold 23,038 shares of Oscar Health stock in a transaction dated Thursday, January 8th. The stock was sold at an average price of $17.65, for a total value of $406,620.70. Following the transaction, the insider owned 350,180 shares in the company, valued at $6,180,677. The trade was a 6.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Janet Liang sold 7,338 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $121,737.42. Following the completion of the sale, the insider owned 172,527 shares in the company, valued at approximately $2,862,222.93. This represents a 4.08% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 483,307 shares of company stock worth $7,635,300. Corporate insiders own 24.39% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Envestnet Asset Management Inc. grew its holdings in shares of Oscar Health by 200.9% during the second quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock worth $648,000 after buying an additional 20,171 shares in the last quarter. Udine Wealth Management Inc. raised its holdings in shares of Oscar Health by 138.4% during the third quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company’s stock worth $2,774,000 after purchasing an additional 85,083 shares during the period. Kingswood Wealth Advisors LLC bought a new position in shares of Oscar Health during the second quarter worth about $576,000. Lane Generational LLC bought a new stake in shares of Oscar Health during the second quarter valued at about $4,800,000. Finally, Q Fund Management Hong Kong Ltd bought a new stake in Oscar Health in the third quarter worth about $5,940,000. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.